• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Monday, June 5, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Research integrity recognized as major problem but new report falls short

Bioengineer by Bioengineer
May 11, 2023
in Science News
Reading Time: 4 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Digital Science welcomes the UK Parliament Select Committee report on research integrity as an important step towards greater transparency and accountability on research quality.

Dr Leslie McIntosh

Credit: Digital Science

Digital Science welcomes the UK Parliament Select Committee report on research integrity as an important step towards greater transparency and accountability on research quality.

However, the technology company argues that such action is long overdue, and doesn’t go far enough by leaving the role that research infrastructure providers can play unexamined. It means the research community could miss out on the crucial support those providers offer in the shape of quantitative evidence.

Dr Leslie McIntosh, Vice President of Research Integrity at Digital Science, says: “We welcome the parliamentary committee’s work on the major research reproducibility issues facing the entire community – not just in the UK, but globally – and to set best practice expectations around responsible, reproducible, and transparent research.

“However, as leaders in the research integrity space, with many decades of experience in championing and supporting open, transparent and reproducible research, we believe the report can and should go further.

“Critically, if the report has a limitation, it leaves the role of some parts of the research community – including the roles of research infrastructure and service providers – unexamined. By examining this broader complexity – including, research infrastructure, institutions and service providers – we can see that solutions to future problems will arise. We genuinely need a holistic approach to these issues. With this in mind, it is timely to reflect on Digital Science’s role in supporting research integrity and reproducibility,” Dr McIntosh says.

The report goes on to put the onus on the system and not researchers or other actors for the failings in research processes, pointing to systemic barriers that prevent best practice. At the core of the report’s 28 individual recommendations to solve these issues is the sentiment that “the research community, including research institutions and publishers, should work alongside individuals to create an environment where research integrity and reproducibility are championed”. (p28).

“This foundational piece – Research Reproducibility – upholds the integrity scholarship. As funders influence the direction of the research ecosystem, the UK report rightly brings reproducibility to the forefront of research, strengthening one vital pillar of trust in science,” Dr McIntosh says.

A more detailed response from Digital Science to the report can be found in this TL;DR blog post from Vice President of Research Futures Simon Porter: Reproducibility and Research Integrity top UK research agenda.

Digital Science has a range of research tools that enable best practice in research quality and integrity, such as the figshare data repository and the new Dimensions Research Integrity product, which uses the methodology and algorithms developed by Digital Science company Ripeta to examine published papers and identify the hallmarks of responsible science – called ‘Trust Markers’. This step forward has created the world’s largest research integrity dataset by applying the processes to over 33 million publications since 2011, resulting in over 200 million trust marker data points which allow researchers to look at the development over time of the portfolios of research organizations, publishers and funders.

Dimensions Research Integrity is one of the first global datasets on Research Integrity practice to be made available – to see what it looks like and learn more about shifts in the structuring of research papers, more details can be found in the blog post on Digital Science’s new TL;DR website. 

Learn more about Dimensions Research Integrity.

About Digital Science

Digital Science is a technology company working to make research more efficient. We invest in, nurture and support innovative businesses and technologies that make all parts of the research process more open and effective. Our portfolio includes admired brands including Altmetric, Dimensions, Figshare, ReadCube, Symplectic, IFI CLAIMS Patent Services, Overleaf, Ripeta, Writefull, and metaphacts. We believe that together, we can help researchers make a difference. Visit www.digital-science.com and follow @digitalsci on Twitter or on LinkedIn.

About Dimensions

Part of Digital Science, Dimensions is the largest linked research database and data infrastructure provider, re-imagining research discovery with access to grants, publications, clinical trials, patents and policy documents all in one place. www.dimensions.ai

About Figshare

Part of Digital Science, Figshare is an open access turnkey Software-as-a-Service repository solution that supports open science. Its infrastructure and global community provide institutions with a platform to share and preserve their outputs – including large datasets – in a findable, accessible, interoperable, and reusable (FAIR) way. Visit figshare.com and follow @figshare on Twitter.

Media contacts

David Ellis, Press, PR & Social Manager, Digital Science: Mobile +61 447 783 023,  [email protected]

Simon Linacre, Head of Content, Brand & Press, Digital Science: Mobile: +44 7484 381477, [email protected]



Share12Tweet8Share2ShareShareShare2

Related Posts

Dr. Alex Herrera

Phase 3 SWOG Cancer Research Network trial, led by a City of Hope researcher, demonstrates one-year progression-free survival in 94% of patients with Stage 3 or 4 classic Hodgkin lymphoma who received a checkpoint inhibitor combined with chemotherapy

June 4, 2023
Ana Oaknin, Principal Investigator of the Vall d’Hebron Institute of Oncology’s (VHIO) Gynecological Malignancies Group

The promise of novel FolRα-targeting antibody drug conjugate in recurrent epithelial ovarian cancer

June 3, 2023

Carbon-based stimuli-responsive nanomaterials: classification and application

June 3, 2023

ASCO: Targeted therapy induces responses in HER2-amplified biliary tract cancer

June 3, 2023

POPULAR NEWS

  • plants

    Plants remove cancer causing toxins from air

    40 shares
    Share 16 Tweet 10
  • Element creation in the lab deepens understanding of surface explosions on neutron stars

    36 shares
    Share 14 Tweet 9
  • Deep sea surveys detect over five thousand new species in future mining hotspot

    35 shares
    Share 14 Tweet 9
  • How life and geology worked together to forge Earth’s nutrient rich crust

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Phase 3 SWOG Cancer Research Network trial, led by a City of Hope researcher, demonstrates one-year progression-free survival in 94% of patients with Stage 3 or 4 classic Hodgkin lymphoma who received a checkpoint inhibitor combined with chemotherapy

The promise of novel FolRα-targeting antibody drug conjugate in recurrent epithelial ovarian cancer

Carbon-based stimuli-responsive nanomaterials: classification and application

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 50 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In